Alpine Immune Sciences

YTD

ALL

Why Robinhood?

You can watch ALPN and buy or sell other stocks, ETFs, and their options commission-free!

About ALPN

Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company, which focusses on discovering and developing protein-based immunotherapies to treat autoimmune and inflammatory diseases. Its product pipeline includes inflammatory diseases, immuno-oncology, and engineered cellular therapies.

CEO

Mitchell H. Gold, MD

CEOMitchell H. Gold, MD

Employees

—

Employees—

Headquarters

Seattle, Washington

HeadquartersSeattle, Washington

Founded

2007

Founded2007

Employees

—

Employees—

ALPN Key Statistics

Market cap

4.26B

Market cap4.26B

Price-Earnings ratio

-93.75

Price-Earnings ratio-93.75

Dividend yield

—

Dividend yield—

Average volume

558.17K

Average volume558.17K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$65.00

52 Week high$65.00

52 Week low

$8.33

52 Week low$8.33

People also own

Based on the portfolios of people who own ALPN. This list is generated using Robinhood data, and it’s not a recommendation.

Taiwan Semiconductor Manu…

Micron Technology